Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2017 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Potent CD4+ T cell-associated antitumor memory responses induced by trifunctional bispecific antibodies in combination with immune checkpoint inhibition.
Deppisch N, Ruf P, Ei├čler N, Lindhofer H, Mocikat R. Deppisch N, et al. Oncotarget. 2017 Jan 17;8(3):4520-4529. doi: 10.18632/oncotarget.13888. Oncotarget. 2017. PMID: 27966460 Free PMC article.
Efficacy and Tolerability of a GD2-Directed Trifunctional Bispecific Antibody in a Preclinical Model: Subcutaneous Administration Is Superior to Intravenous Delivery.
Deppisch N, Ruf P, Eissler N, Neff F, Buhmann R, Lindhofer H, Mocikat R. Deppisch N, et al. Mol Cancer Ther. 2015 Aug;14(8):1877-83. doi: 10.1158/1535-7163.MCT-15-0156. Epub 2015 Jun 10. Mol Cancer Ther. 2015. PMID: 26063765 Free article.
Potential of the trifunctional bispecific antibody surek depends on dendritic cells: rationale for a new approach of tumor immunotherapy.
Eissler N, Mysliwietz J, Deppisch N, Ruf P, Lindhofer H, Mocikat R. Eissler N, et al. Among authors: deppisch n. Mol Med. 2013 Apr 30;19(1):54-61. doi: 10.2119/molmed.2012.00140. Mol Med. 2013. PMID: 23552725 Free PMC article.